CVE-2026-120974: Arista Networks EOS · Authentication Bypass by Capture-replay
Affects Arista Networks EOSSource CVE Database V5
Not known to be exploited · CVSS 5.3 Medium · fixed in 4.33.0F : update Arista Networks EOS when convenient.
Data as of 10 Nov 2026, 20:34 UTC
Thin evidence
One scorer or none| CNA (Arista) | CVSS 3.1 | 5.3 |
|---|---|---|
| CNA (Arista) | CVSS 4.0 | 6.9 |
- Patch
- Available – fixed in 4.33.0F, 4.32.0F, 4.31.0F +2
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:LExploitation evidence
Disclosed: evidence found.
CVE published 10 Nov 2026
Detectable: no evidence on record.
No public nuclei template indexed
Weaponized: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors
A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 10 Nov 2026.
What to do
Upgrade to a fixed release listed under Affected software.
Affected software
| Product | Affected | Fixed in |
|---|---|---|
| Arista NetworksEOS | Affected
| Fixed in
|
AI-suggested
Fixed versions are available starting from 4.28.0F, 4.30.0F, 4.31.0F, 4.32.0F, and 4.33.0F. Operators should upgrade affected EOS versions to these fixed releases to ensure proper enforcement of IPsec anti-replay protection. No other mitigations or workarounds are indicated.
Description
CVE-2026-120974 is an authentication bypass vulnerability in Arista Networks EOS affecting the IPsec AutoVPN feature with dynamic paths. The IPsec replay window may not be enforced as configured, causing the anti-replay protection to be silently inactive. This does not allow decryption of IPsec traffic but may permit replay of previously valid protected traffic. The issue affects multiple versions of EOS prior to fixed releases. The vulnerability has a medium severity rating with a CVSS score of 5.3.